Top Markets
Coin of the day
MDxHealth S.A. MDxHealth S.A.

MDxHealth S.A.

MDXH
株式のランク #21732
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
株価
$3.58
最終同期: 2023-12-15
時価総額
$101.57M
変化(1日)
3.79%
変化(1年)
0.00%
BE
取引 MDxHealth S.A. (MDXH)

カテゴリー

MDxHealth S.A.(MDXH)の配当履歴
MDxHealth S.A.(証券コード:MDXH)は合計で0回の配当を行いました。
すべての配当の合計(株式分割調整済み)は:0.00
配当利回り(TTM):0
2026から2026までのMDxHealth S.A.(MDXH)の配当履歴
年間配当支払い
配当(株式分割調整済み) 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴